Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
EPR-C EPR Properties
CNTA Centessa Pharmaceuticals PLC
ZVSA Zyversa Therapeutics Inc
MYMD MyMD Pharmaceuticals Inc
$NQUSS302050EUR Nasdaq US Small Cap Open End and Mis
JOBY Joby Aviation Inc
RVLP RVL Pharmaceuticals PLC
PDO PIMCO Dynamic Income Opportunities Fund
BOCT Innovator U.S. Equity Buffer ETF™ October
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. The Company's commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases. It helps in accelerating and improving the traditional drug development process through its VelociSuite technologies, such as VelocImmune, which uses genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through research initiatives, such as Regeneron Genetics Center. It operates gene therapy programs targeting different forms of congenital, monogenic hearing loss. Its advanced clinical-stage candidate is DB-OTO, which is an investigational cell-selective, adeno-associated virus (AAV) gene therapy.

Price
Delayed
$811.95
Day's Change
3.64 (0.45%)
Bid
--
Ask
--
B/A Size
--
Day's High
815.27
Day's Low
805.93
Volume
(Light)

Today's volume of 29,163 shares is on pace to be much lighter than REGN's 10-day average volume of 412,657 shares.

29,163
  • Prev Close
    808.31
  • Today's Open
    809.16
  • Day's Range
    805.93-815.27
  • Avg Vol (10-day)
    412.7K
  • Last (time)
    10:42a ET 10/04/23
  • Last (size)
    100
  • 52-Wk Range
    668.00 - 847.50
    LowHigh
  • (01/09/23 - 08/23/23)
    4.19%
  • 25.9%
  • Market Cap
    88.1B
  • Shares Outstanding
    108.6M
  • 37.83
  • 21.37x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.1
  • 88.46
  • (% of float 09/15/23)
    1.40

Latest News

October 04, 2023
8:27 am ET
Zacks
October 03, 2023
4:43 pm ET
MarketWatch
7:00 am ET
Globe Newswire
7:00 am ET
Globe Newswire
October 02, 2023
4:43 pm ET
MarketWatch
September 29, 2023
4:43 pm ET
MarketWatch
8:30 am ET
Globe Newswire
September 28, 2023
4:43 pm ET
MarketWatch
4:05 pm ET
Globe Newswire
September 27, 2023
4:43 pm ET
MarketWatch
September 26, 2023
4:43 pm ET
MarketWatch
7:11 am ET
Zacks
1:29 am ET
Globe Newswire
September 25, 2023
5:13 pm ET
Globe Newswire
4:43 pm ET
MarketWatch
8:34 am ET
Globe Newswire
8:07 am ET
Zacks
September 22, 2023
4:43 pm ET
MarketWatch
1:57 pm ET
Zacks
September 21, 2023
4:43 pm ET
MarketWatch
September 20, 2023
5:02 pm ET
BusinessWire
4:43 pm ET
MarketWatch
9:00 am ET
BusinessWire
September 19, 2023
4:43 pm ET
MarketWatch
September 18, 2023
4:43 pm ET
MarketWatch
September 15, 2023
4:43 pm ET
MarketWatch
8:41 am ET
MarketWatch
September 14, 2023
4:43 pm ET
MarketWatch
September 13, 2023
4:43 pm ET
MarketWatch
September 12, 2023
4:44 pm ET
MarketWatch
September 11, 2023
4:43 pm ET
MarketWatch
September 08, 2023
5:03 pm ET
MarketWatch
4:46 pm ET
Globe Newswire
4:45 pm ET
Globe Newswire
4:43 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.